ResearcherNew York UniversityActive in the last 2 years
Brian J. Kaplan
Matched on ORCID iD 0009-0005-0686-5544; OpenAlex author ID A5025524233. Sources: OpenAlex.
Their work
- Papers
- 11 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 31
2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 3 papers · 2025: 3 papers · 2026: 1 paper
Papers 11
- Clinical and molecular features of resected early onset pancreatic ductal adenocarcinoma: insights from the NCDB and cBioPortal. Co-author DOI 10.1016/j.hpb.2025.12.026↗
- Moving Beyond the Standard Pancreatectomy for Pancreatic Adenocarcinoma. Co-author DOI 10.1016/j.semradonc.2025.08.001↗
- Impact of resection margin status on recurrence and survival in patients with resectable, borderline resectable, and locally advanced pancreatic cancer. Co-author DOI 10.1016/j.surg.2024.109114↗
- The Impact of Social Determinants of Health on Supportive and Palliative Care in Pancreatic Cancer Management: A Narrative Review. Co-author DOI 10.3390/cancers17193254↗
- The impact of metastatic sites on survival Rates and predictors of extended survival in patients with metastatic pancreatic cancer. Co-author DOI 10.1016/j.pan.2024.06.004↗
- Progression of Site-specific Recurrence of Pancreatic Cancer and Implications for Treatment. Co-author DOI 10.1097/sla.0000000000006142↗
- Development of a Composite Score Based on Carbohydrate Antigen 19-9 Dynamics to Predict Survival in Carbohydrate Antigen 19-9-Producing Patients With Pancreati… Co-author DOI 10.1200/po.24.00193↗
- The impact of race/ethnicity on pancreaticoduodenectomy outcomes for pancreatic cancer. Last author DOI 10.1002/jso.27113↗
- CivaSheet intraoperative radiation therapy for pancreatic cancer. Co-author DOI 10.1016/j.brachy.2021.10.007↗
- First report on the feasibility of a permanently implantable uni-directional planar low dose rate brachytherapy sheet for patients with resectable or borderlin… Co-author DOI 10.1016/j.brachy.2020.08.010↗
- Changing paradigm in pancreatic cancer: from adjuvant to neoadjuvant chemoradiation. Co-author DOI 10.21037/jgo.2016.11.09↗
Closest collaborators
The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Greg D. Sacks · 7 shared papers, 2024–2026 · strength 1.57
- Paper Clinical and molecular features of resected early onset pancreatic ductal adenocarcinoma: insights from the NCDB and cB… DOI 10.1016/j.hpb.2025.12.026↗
- Paper Moving Beyond the Standard Pancreatectomy for Pancreatic Adenocarcinoma. DOI 10.1016/j.semradonc.2025.08.001↗
- Paper The Impact of Social Determinants of Health on Supportive and Palliative Care in Pancreatic Cancer Management: A Narrat… DOI 10.3390/cancers17193254↗
- Daniel Brock Hewitt · 6 shared papers, 2024–2026 · strength 1.28
- Paper Clinical and molecular features of resected early onset pancreatic ductal adenocarcinoma: insights from the NCDB and cB… DOI 10.1016/j.hpb.2025.12.026↗
- Paper The Impact of Social Determinants of Health on Supportive and Palliative Care in Pancreatic Cancer Management: A Narrat… DOI 10.3390/cancers17193254↗
- Paper Impact of resection margin status on recurrence and survival in patients with resectable, borderline resectable, and lo… DOI 10.1016/j.surg.2024.109114↗
- Christopher Lee Wolfgang · 6 shared papers, 2024–2026 · strength 1.28
- Paper Clinical and molecular features of resected early onset pancreatic ductal adenocarcinoma: insights from the NCDB and cB… DOI 10.1016/j.hpb.2025.12.026↗
- Paper The Impact of Social Determinants of Health on Supportive and Palliative Care in Pancreatic Cancer Management: A Narrat… DOI 10.3390/cancers17193254↗
- Paper Impact of resection margin status on recurrence and survival in patients with resectable, borderline resectable, and lo… DOI 10.1016/j.surg.2024.109114↗
- Ammar A. Javed · 6 shared papers, 2024–2026 · strength 1.28
- Paper Clinical and molecular features of resected early onset pancreatic ductal adenocarcinoma: insights from the NCDB and cB… DOI 10.1016/j.hpb.2025.12.026↗
- Paper The Impact of Social Determinants of Health on Supportive and Palliative Care in Pancreatic Cancer Management: A Narrat… DOI 10.3390/cancers17193254↗
- Paper Impact of resection margin status on recurrence and survival in patients with resectable, borderline resectable, and lo… DOI 10.1016/j.surg.2024.109114↗
- Ingmar Florin Rompen · 5 shared papers, 2024–2026 · strength 1.05
- Paper Clinical and molecular features of resected early onset pancreatic ductal adenocarcinoma: insights from the NCDB and cB… DOI 10.1016/j.hpb.2025.12.026↗
- Paper Impact of resection margin status on recurrence and survival in patients with resectable, borderline resectable, and lo… DOI 10.1016/j.surg.2024.109114↗
- Paper The impact of metastatic sites on survival Rates and predictors of extended survival in patients with metastatic pancre… DOI 10.1016/j.pan.2024.06.004↗
- Joseph R. Habib · 5 shared papers, 2024–2025 · strength 0.98
- Paper The Impact of Social Determinants of Health on Supportive and Palliative Care in Pancreatic Cancer Management: A Narrat… DOI 10.3390/cancers17193254↗
- Paper Impact of resection margin status on recurrence and survival in patients with resectable, borderline resectable, and lo… DOI 10.1016/j.surg.2024.109114↗
- Paper The impact of metastatic sites on survival Rates and predictors of extended survival in patients with metastatic pancre… DOI 10.1016/j.pan.2024.06.004↗
- Jonah M. Levine · 3 shared papers, 2024–2025 · strength 0.58
- Paper Impact of resection margin status on recurrence and survival in patients with resectable, borderline resectable, and lo… DOI 10.1016/j.surg.2024.109114↗
- Paper The impact of metastatic sites on survival Rates and predictors of extended survival in patients with metastatic pancre… DOI 10.1016/j.pan.2024.06.004↗
- Paper Progression of Site-specific Recurrence of Pancreatic Cancer and Implications for Treatment. DOI 10.1097/sla.0000000000006142↗
- Michael D. Kluger · 2 shared papers, 2025 · strength 0.51
- Nabiha Akhlaq Mughal · 2 shared papers, 2024–2026 · strength 0.49
- Emma Charlotte Fields · 3 shared papers, 2016–2022 · strength 0.45
- Paper CivaSheet intraoperative radiation therapy for pancreatic cancer. DOI 10.1016/j.brachy.2021.10.007↗
- Paper First report on the feasibility of a permanently implantable uni-directional planar low dose rate brachytherapy sheet f… DOI 10.1016/j.brachy.2020.08.010↗
- Paper Changing paradigm in pancreatic cancer: from adjuvant to neoadjuvant chemoradiation. DOI 10.21037/jgo.2016.11.09↗
- Omar Mahmud · 1 shared paper, 2026 · strength 0.30
- Madeleine D Hunter · 1 shared paper, 2025 · strength 0.28
- Christopher L. Wolfgang · 1 shared paper, 2025 · strength 0.28
- Kate Mlouk · 1 shared paper, 2025 · strength 0.28
- Sterre van Herwijnen · 1 shared paper, 2025 · strength 0.23
- Vijayvel Jayaprakash · 1 shared paper, 2025 · strength 0.23
- Camila Hidalgo Salinas · 1 shared paper, 2025 · strength 0.23
- Alessio Marchetti · 1 shared paper, 2025 · strength 0.21
- Ross J. Taylor · 1 shared paper, 2022 · strength 0.20
- Yahya Ahmed Alwatari · 1 shared paper, 2023 · strength 0.18
- Brian E. Diskin · 1 shared paper, 2024 · strength 0.18
- Diane M. Simeone · 1 shared paper, 2024 · strength 0.18
- Jose Gilberto Trevino · 1 shared paper, 2023 · strength 0.18
- Joshua B. Dault · 1 shared paper, 2021 · strength 0.17
- Jonathan Garnier · 1 shared paper, 2024 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.